TIP_link_300x300.jpg
Electronic Data Interchange (EDI) Market Worth $65.99 Billion, Globally, by 2031 - Exclusive Report by The Insight Partners
September 23, 2024 07:08 ET | The Insight Partners
US & Canada, Sept. 23, 2024 (GLOBE NEWSWIRE) -- According to a new comprehensive report from The Insight Partners, the global electronic data interchange (EDI) market is observing significant...
Goliath BC - logo with gradient gold-justified.png
Mr. Roger Rosmus, Founder & CEO Of Goliath To Present At Noble Capital Markets’ Basic Industries Emerging Growth Virtual Equity Conference, Wednesday September 25th, 2024
September 23, 2024 07:08 ET | Goliath Resources Limited
TORONTO, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Goliath Resources Limited (TSX-V: GOT) (OTCQB: GOTRF) (FSE: B4IF) (the “Company” or “Goliath”) is pleased to announce that Mr. Roger Rosmus, Founder...
22157.jpg
IgG Mediated Autoimmune Diseases Biologic Drugs Research Report 2024: Humanized, Fully Human, Chimeric, Other Sources Insights and Forecasts 2019-2023 & 2024-2029
September 23, 2024 07:07 ET | Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "Global IgG Mediated Autoimmune Diseases Biologic Drugs Market (2024 Edition): Analysis By Antibody Source (Humanized, Fully Human, Chimeric, Other...
22157.jpg
China Embedded Finance Business and Investment Opportunities Databook 2024: CAGR of 24.9% Forecast from 2024 to 2029, with Market to Reach $132.46 Billion by 2029 
September 23, 2024 07:05 ET | Research and Markets
Dublin, Sept. 23, 2024 (GLOBE NEWSWIRE) -- The "China Embedded Finance Business and Investment Opportunities Databook - 75+ KPIs on Embedded Lending, Insurance, Payment, and Wealth Segments - Q2...
Logo-uniQure-MS-Word_Orange.jpg
uniQure Announces Orphan Drug Designation Granted to AMT-191 for the Treatment of Fabry Disease
September 23, 2024 07:05 ET | uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, Sept. 23, 2024 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
KBLB logo.jpg
Kraig Biocraft Laboratories Launches Spider Silk Production at Recently Completed Higher Capacity Facility
September 23, 2024 07:05 ET | Kraig Biocraft Laboratories
Kraig Labs (OTCQB:KBLB) begins first BAM-1 parental strains production at its new production center with capacity to support 25 tons of spider silk
Invivyd logo_
Invivyd Provides Detailed Virology Data and Analysis of SARS-CoV-2 Structural Biology Predicting Anticipated Neutralization Activity for PEMGARDA™ (pemivibart)
September 23, 2024 07:01 ET | Invivyd
Independent evaluation of KP.3.1.1 and LB.1 variants shows in vitro pseudovirus neutralization potency of PEMGARDA in-line with prior variants testedProprietary, ongoing SARS-CoV-2 spike analyses...
outbrain_logo.png
Outbrain announces repurchase of remaining 2.95% Convertible Senior Notes due 2026
September 23, 2024 07:00 ET | Outbrain Inc.
NEW YORK, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Outbrain Inc. (NASDAQ: OB), a leading technology platform that drives business results by engaging people across the Open Internet, announced today that...
bitfarms.jpg
Bitfarms and Riot Announce Settlement
September 23, 2024 07:00 ET | Bitfarms Ltd.; Riot Platforms Inc.
- Andrés Finkielsztain Steps Down from Board - - Bitfarms Appoints Amy Freedman to Board of Directors - - Board to Nominate an Independent Director for Election at Special Meeting - - Standstill...
Orgenesis Logo.jpg
Orgenesis Announces Reverse Stock Split
September 23, 2024 07:00 ET | Orgenesis Inc.
GERMANTOWN, Md., Sept. 23, 2024 (GLOBE NEWSWIRE) -- Orgenesis Inc. (Nasdaq:ORGS) (“Orgenesis” or the “Company”) today announced that its Board of Directors has approved a 1-for-10 reverse stock...